NCT01276652

Brief Summary

This study examines the feasibility of assessing sleep and circadian rhythmicity in critically ill patients undergoing mechanical ventilation. Secondarily, it will examine the feasibility of reducing subject exposure to environmental light and noise and of delivering routine care according to classical day/night routines.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2001

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2001

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

January 10, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 13, 2011

Completed
6.7 years until next milestone

Results Posted

Study results publicly available

September 26, 2017

Completed
Last Updated

September 26, 2017

Status Verified

July 1, 2017

Enrollment Period

7.1 years

First QC Date

January 10, 2011

Results QC Date

December 29, 2016

Last Update Submit

July 25, 2017

Conditions

Keywords

PolysomnographyCircadian rhythmicity

Outcome Measures

Primary Outcomes (1)

  • Percentage of Subjects Who Successfully Undergo Continuous Bedside Polysomnography for at Least 24 Hours.

    This study assesses the feasibility of studying sleep and circadian rhythmicity in acutely ill, mechanically ventilated patients through the application of continuous bedside polysomnography. Feasibility will be assessed by determining the percentage of enrolled subjects who undergo at least 24 hours of continuous bedside polysomnography.

    Average 4 days (patients followed to hospital discharge)

Secondary Outcomes (1)

  • Subject Tolerance of the Environmental Modification Protocol

    Average 4 days (patients followed to hospital discharge)

Other Outcomes (2)

  • Occurrence of REM Sleep

    Average 4 days (patients followed to hospital discharge)

  • Normal Timing of 6-sulfatoxymelatonin Excretion

    Average 4 days (patients followed to hospital discharge)

Study Arms (3)

Environmental modification

ACTIVE COMPARATOR

Subjects assigned to this group receive the environmental modification intervention for 48 hours beginning the morning after enrollment.

Behavioral: Environmental modification

Usual care (randomized)

NO INTERVENTION

Usual care is provided for the first 48 hours. Subsequently, in the initial protocol, subjects received 48 hours of the environmental modification intervention so long as they remained in the ICU during this time. The opportunity to receive the "Delayed" intervention was later removed from the protocol.

Usual care (observational)

NO INTERVENTION

Usual care was provided.

Interventions

Environmental modification consists of nursing-related efforts to optimize daytime light exposure, to minimize nighttime light and noise exposure, and to batch nursing care at night.

Environmental modification

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults undergoing mechanical ventilation in the medical intensive care unit.

You may not qualify if:

  • Central nervous system disease (stroke, seizure, dementia, etc)
  • Metabolic or hypoxic encephalopathy
  • Confirmed or suspected drug overdose
  • Currently receiving neuromuscular blockers
  • Coma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago

Chicago, Illinois, 60637, United States

Location

MeSH Terms

Conditions

Respiratory InsufficiencyCritical Illness

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Limitations and Caveats

Logistical issues related to the performance of continuous bedside polysomnography may vary from institution to institution, thereby limiting the generalizability of our results where the primary outcome measure is concerned.

Results Point of Contact

Title
Brian Gehlbach, MD
Organization
University of Iowa

Study Officials

  • Brian K Gehlbach, MD

    University of Chicago

    PRINCIPAL INVESTIGATOR
  • Jesse Hall, MD

    University of Chicago

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Subjects were randomized in 1:1 fashion to receive the Environmental Modification protocol or usual care. Subsequently a third, observational arm was opened to acquire more physiologic data.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor of Medicine

Study Record Dates

First Submitted

January 10, 2011

First Posted

January 13, 2011

Study Start

November 1, 2001

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

September 26, 2017

Results First Posted

September 26, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

As this is a pilot study, there are no plans to share IPD.

Locations